Protalix Biotherapeutics shares owned by Highbridge Capital Management
Quarter-by-quarter ownership of Protalix Biotherapeutics shares owned by Highbridge Capital Management
from 13F filings
Historical chart of Highbridge Capital Management investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Protalix Biotherapeutics by Highbridge Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $13B | 13M | 1044.18 |
2023-12-31 | $15B | 13M | 1185.00 |
2023-09-30 | $145k | 13M | 0.01 |
2023-06-30 | $15M | 13M | 1.20 |
2023-03-31 | $180k | 15M | 0.01 |
2022-12-31 | $16M | 15M | 1.04 |
2022-06-30 | $15M | 15M | 1.02 |
2022-03-31 | $17M | 15M | 1.16 |
2021-12-31 | $14M | 15M | 0.94 |
More positions owned by Highbridge Capital Management
View all positions for Highbridge Capital Management
Top funds holding Protalix Biotherapeutics
View all funds holding Protalix Biotherapeutics